G.E.T. Recalls Sports Supplement

PHOENIXGenetic Edge Technologies (G.E.T.) announced a national voluntary recall of all lots of its ArimaDex sports nutrition supplement as it may contain an aromatase inhibitor, a type of drug used in breast cancer treatment that stops the bodys production of estrogen. FDA informed the company of potential adverse events associated with the use of aromatase inhibitors, including infertility, adrenal insufficiencies, and kidney and liver dysfunction. The agency concluded products containing aromatase inhibitors are likely to cause adverse reactions in at-risk consumers, including those with liver, kidney, adrenal or prostate concerns.

ArimaDex is marketed as a pharmaceutical grade anabolic supplement," containing ingredients including calcium D-glucarate, resveratrol, diindolemethane (DIM), Tribulus terrestris, Vitex angus Castus and Rhodiola rosea; it is marketed for its ability to enhance and maintain testosterone levels. The product is sold in 60-count softgel bottles, UPC Code 718122466511. While the company has received no adverse event reports, it suggests consumers return the product for a refund.

Consumers who do have adverse reactions to the use of ArimaDex can report the situation to FDA via the MedWach Adverse Event Reporting program online.